Truncation in parallel studies [Design Issues]

posted by rana – India, 2012-01-06 11:07 (5286 d 08:30 ago) – Posting: # 7872
Views: 3,334

Is it acceptable for long half life drugs (>24 hrs) Truncation (AUC upto 72.0 hr) in case of parallel studies for Europe regulatory??

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
379 visitors (0 registered, 379 guests [including 13 identified bots]).
Forum time: 20:37 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5